LMR Partners’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-249,999
| Closed | -$362K | – | 1050 |
|
|
2024
Q1 | $362K | Hold |
249,999
| – | – | ﹤0.01% | 396 |
|
|
2023
Q4 | $25K | Hold |
249,999
| – | – | ﹤0.01% | 503 |
|
|
2023
Q3 | $37.5K | Buy |
249,999
+49,999
| +25% | +$7.5K | ﹤0.01% | 537 |
|
|
2023
Q2 | $18K | Hold |
200,000
| – | – | ﹤0.01% | 608 |
|
|
2023
Q1 | $2.03M | Hold |
200,000
| – | – | 0.03% | 422 |
|
|
2022
Q4 | $2.01M | Hold |
200,000
| – | – | 0.04% | 519 |
|
|
2022
Q3 | $1.97M | Hold |
200,000
| – | – | 0.04% | 538 |
|
|
2022
Q2 | $1.96M | Hold |
200,000
| – | – | 0.03% | 547 |
|
|
2022
Q1 | $1.96M | Hold |
200,000
| – | – | 0.02% | 582 |
|
|
2021
Q4 | $1.94M | Hold |
200,000
| – | – | 0.02% | 493 |
|
|
2021
Q3 | $1.95M | Hold |
200,000
| – | – | 0.02% | 467 |
|
|
2021
Q2 | $200K | Buy |
+200,000
| New | +$200K | ﹤0.01% | 781 |
|